RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA Enforcement In 2025: What The Data Reveals So Far The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System